Close Menu

NEW YORK – Evonetix announced Monday a partnership with Belgium-based nanoelectronics firm Imec to increase the scale of production of Evonetix's silicon chips for use in DNA synthesis.

Under the agreement, the firms will work together to scale up manufacturing of Evonetix's microelectromechanical systems-based chips on 8-inch silicon wafers.

"With the support of Imec, a world-renowned leader in microchip technology, we will be able to optimize our highly parallel desktop platform for commercial supply," Evonetix CTO Matthew Hayes said in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Two COVID-19 vaccine developers have released their trial protocols to build public trust, the New York Times reports.

A new analysis finds the rapid COVID-19 test from DnaNudge to be highly accurate, Reuters reports.

In Science this week: global citizens' assembly on genome-editing technologies proposed, epigenetic markers predict metformin response, and more.

According to the Verge, many US states are not including positive results from rapid COVID-19 testing in their case numbers.